pk 11195 and ac-5216
pk 11195 has been researched along with ac-5216 in 3 studies
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Hatori, A; Kawamura, K; Kumata, K; Odawara, C; Suzuki, K; Yamasaki, T; Yanamoto, K; Yui, J; Zhang, MR | 1 |
| Anzini, M; Biggio, G; Bini, G; Cappelli, A; Concas, A; Di Cesare Mannelli, L; Ghelardini, C; Giordani, A; Giorgi, G; Giuliani, G; Makovec, F; Paolino, M; Porcu, P; Stasi, LP; Valenti, S; Vomero, S | 1 |
| Chua, SW; Ittner, LM; Kassiou, M; Munoz, L; Reekie, TA; Sokias, R; Werry, EL; Wong, ECN | 1 |
Other Studies
3 other study(ies) available for pk 11195 and ac-5216
| Article | Year |
|---|---|
[18F]FEAC and [18F]FEDAC: Two novel positron emission tomography ligands for peripheral-type benzodiazepine receptor in the brain.
Topics: Animals; Brain; Chemistry, Pharmaceutical; Drug Design; Fluorine Radioisotopes; Humans; Inflammation; Ligands; Male; Models, Chemical; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, GABA-A | 2009 |
Synthesis and structure-activity relationship studies in translocator protein ligands based on a pyrazolo[3,4-b]quinoline scaffold.
Topics: Animals; Anti-Anxiety Agents; Carrier Proteins; Cerebral Cortex; Crystallography, X-Ray; Humans; In Vitro Techniques; Ligands; Male; Mice; Models, Molecular; Mononeuropathies; Pyrazoles; Quinolines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, GABA; Receptors, GABA-A; Structure-Activity Relationship | 2011 |
Determination and reduction of translocator protein (TSPO) ligand rs6971 discrimination.
Topics: | 2017 |